Oral

[O1-4] DNA 1

Tue. Oct 29, 2019 1:00 PM - 2:00 PM Room 4 (Heian)

Chair：
Shuetsu Fukushi (Department of Virology 1, National Institute of Infectious Diseases)
Masahiro Fujimuro (Department of Cell Biology,Kyoto Pharmaceutical Univsersity)

+Add all to schedule

1:00 PM - 1:15 PM

[O1-4-01] Antiviral effect of FIT-039, a selective CDK9 inhibitor, for clinical strains of HSVs

*Shinichi Esaki^1,2, Fumi Goshima², Gaku Takano^1,2, Toru Daikoku⁴, Takahiro Watanabe², Yoshitaka Sato², Takayuki Murata^2,3, Yukihiro Nishiyama², Hiroshi Kimura² (1. Nagoya City University, 2. Nagoya University, 3. Fujita Health University, 4. Hokuriku University)

1:15 PM - 1:30 PM

[O1-4-02] Analysis of action mechanism of an anti-HSV-1 compound from fermented grape pomace

*HANAKO ISHIMARU ISHIMARU¹, Chie Ohta Ohta^3,2, Seiko Nakamura Nakamura², Hisashi Matsuda Matsuda², Tadashi Watanabe Watanabe¹, Masahiro Fujimuro Fujimuro¹ (1. Department of Cell Biology Kyoto Pharmaceutical University, 2. Department of Pharmacognosy Kyoto Pharmaceutical University, 3. Faculty of Pharmaceutical SciencesNagasaki International University)

1:30 PM - 1:45 PM

[O1-4-03] Identification of the Capsid Binding Site in the Herpes Simplex Virus 1 Nuclear Egress Complex and Its Role in Viral Primary Envelopment and Replication

*Kosuke Takeshima¹, Jun Arii¹, Yuhei maruzuru¹, Naoto Koyanagi¹, Akihisa Kato¹, Yasushi Kawaguchi¹ (1. The Institute of Medical Science, The University of Tokyo)

1:45 PM - 2:00 PM

[O1-4-04] Antiviral and anti-inflammatory effects of tricin are stronger than acyclovir on varicella-zoster virus-infected human retinal Muller cell line.

*Masaya Takemoto¹, Hana Minei¹, Hidetaka Sadanari¹, Keiko Matsubara¹, Tsugiya Murayama¹, Tohru Daikoku¹ (1. Hokuriku University)

Session information